Playlist


Turkmen Ambassador Conducts Talks with Head of Kyrgyz Parliament in Bishkek
02 Jun. 11:53An official meeting was held in the capital of the Kyrgyz Republic between Nury Golliev, the head of the Turkmen diplomatic mission, and Marat Mamataliyev, the Chairman of the Jogorku Kenesh. During the discussion, the parties conducted a comprehensive review of the current state of interstate relations and evaluated the strategic prospects for their further expansion. This information was released by the official diplomatic mission of Turkmenistan in Bishkek.
During the negotiation process, the interlocutors paid special attention to advancing the multi-vector partnership, which encompasses trade, economic, legislative, and cultural-humanitarian spheres. The participants noted the presence of steady momentum in the cooperation between the two friendly Central Asian nations. The importance of maintaining regular contacts to promptly address pressing issues on the bilateral agenda was strongly emphasized.
A key point on the agenda was the strengthening of parliamentary dialogue, which serves as a reliable foundation for deepening mutual trust between the two countries. The diplomat and the head of the legislative body emphasized the necessity of activating the operations of joint parliamentary friendship groups. Closer interaction between the relevant legislative committees is expected to significantly accelerate the exchange of expertise in lawmaking and state administration.
For his part, the head of the diplomatic mission reaffirmed Ashgabat's steadfast commitment to deepening mutually beneficial cooperation with Bishkek across all priority sectors. At the conclusion of the meeting, the parties outlined the schedule for future reciprocal visits of high-level delegations. They also discussed the coordination of actions and mutual support for initiatives within major international and inter-parliamentary organizations.
Also read


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.